Favorable risk
Showing 1 - 25 of >10,000
Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),
Recruiting
- Oropharynx Cancer
- Radiation therapy (5 days for 7 weeks)
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 5, 2023
Breast Cancer Trial in Worthington, Fargo, Sioux Falls (IMRT/VMAT-Based Accelerated Partial Breast Irradiation)
Recruiting
- Breast Cancer
- IMRT/VMAT-Based Accelerated Partial Breast Irradiation
-
Worthington, Minnesota
- +2 more
Nov 11, 2022
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Prostate Cancer Trial in Toronto (SABR + HDR)
Recruiting
- Prostate Cancer
- SABR + HDR
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jun 12, 2022
Breast Cancer Radiation Trial in United States (Prosigna)
Active, not recruiting
- Breast Cancer Radiation
- Prosigna
-
Baltimore, Maryland
- +5 more
Jul 7, 2022
COVID, Corona Virus Infection, Adverse Event Trial in New York (EPIC risk score display)
Completed
- COVID
- +2 more
- EPIC risk score display
-
New York, New YorkNYU Langone Health
Dec 22, 2022
Prostate Cancer Trial in Chicago (Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the
Not yet recruiting
- Prostate Cancer
- Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the prostate
-
Chicago, IllinoisNorthwestern University
Jun 17, 2022
Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, China
- +1 more
Aug 18, 2022
Prostate Cancer Trial in Ann Arbor, Detroit, Holland (Decipher, Prolaris, Oncotype Dx Genomic Prostate Score (GPS))
Recruiting
- Prostate Cancer
- Decipher
- +3 more
-
Ann Arbor, Michigan
- +3 more
Oct 26, 2021
Prostate Cancer, Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Trial in San
Recruiting
- Prostate Cancer
- Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
- TRANBERG®|Thermal Therapy System
-
San Diego, CaliforniaGenesis Research LLC.
Apr 12, 2023
PROSTATE CANCER Trial in Petah Tikva (Two-fraction stereotactic radiotherapy, Five-fraction stereotactic radiotherapy)
Recruiting
- PROSTATE CANCER
- Two-fraction stereotactic radiotherapy
- Five-fraction stereotactic radiotherapy
-
Petah Tikva, IsraelDavidoff Cancer Center, Rabin Medical Center
Sep 7, 2023
Hemophilia A, Prophylaxis of Bleeding Trial (Damoctocog alfa-pegol (Jivi, BAY94-9027))
Not yet recruiting
- Hemophilia A
- Prophylaxis of Bleeding
- Damoctocog alfa-pegol (Jivi, BAY94-9027)
- (no location specified)
Jul 26, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (RT plus Nimotuzumab, RT plus Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
- RT plus Nimotuzumab
- RT plus Cisplatin
-
Guangzhou, Guangdong, ChinaSun Yat-sen Universitty Cancer Center
Nov 3, 2021
Prostate Cancer Trial in United States (Prolaris Testing)
Terminated
- Prostate Cancer
- Prolaris Testing
-
Homewood, Alabama
- +33 more
Jun 17, 2022
Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High dose rate prostate brachytherapy)
Recruiting
- Prostate Cancer
- Low dose rate prostate brachytherapy
- High dose rate prostate brachytherapy
-
Kelowna, British Columbia, CanadaBritish Columbia Cancer Agency Center for the Southern Interior
Oct 15, 2020
Adenocarcinoma of the Prostate Trial in Dijon (Stereotactic Radiotherapy with Linac MRI)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiotherapy with Linac MRI
-
Dijon, FranceCentre Georges François Leclerc
May 27, 2021
Acute Myeloid Leukemia, Minimal Residual Disease Negativity Trial in Seattle (procedure, drug, other)
Withdrawn
- Acute Myeloid Leukemia
- Minimal Residual Disease Negativity
- Autologous Hematopoietic Stem Cell Transplantation
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 27, 2021
Prostate Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues Trial in Philadelphia (radiation therapy)
Completed
- Prostate Cancer
- +2 more
- radiation therapy
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Feb 9, 2021
Prostate Cancer Trial in Loma Linda (Proton Radiation, Proton)
Completed
- Prostate Cancer
- Proton Radiation
- Proton
-
Loma Linda, CaliforniaLoma Linda University Medical Center / James M. Slater Proton Tr
Feb 4, 2020
Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity
Completed
- Childhood Favorable Prognosis Hodgkin Lymphoma
- +5 more
- radiation therapy
- +11 more
-
Arcadia, CaliforniaChildren's Oncology Group
Mar 26, 2021
Sleep Apnea, Obstructive Trial (Genio System)
Not yet recruiting
- Sleep Apnea, Obstructive
- Genio System
- (no location specified)
Oct 20, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Prostate Cancer Trial in France (F-HIFU, Radical Prostatectomy)
Not yet recruiting
- Prostate Cancer
- F-HIFU
- Radical Prostatectomy
-
Aix-en-Provence, France
- +18 more
Jan 25, 2023
Solid Tumor, Adult, Metastasis Trial in West Islip (Palliative and Survivorship Care Model)
Recruiting
- Solid Tumor, Adult
- Metastasis
- Palliative and Survivorship Care Model
-
West Islip, New YorkGood Samaritan University Hospital
Jul 7, 2023
HIV, Tuberculosis, Smoking Cessation Trial in Rondebosch (QUIT-AD, Enhanced Treatment as Usual)
Not yet recruiting
- HIV Infections
- +2 more
- QUIT-AD
- Enhanced Treatment as Usual
-
Rondebosch, South AfricaUniversity of Cape Town
Apr 24, 2023